Kathryn Guarini exercised Options for 400 Regeneron shares at $719.37 per share on Sept. 2, 2026. After the related transactions, her reported holdings were 603 shares and 1,158 derivative securities, giving investors the stated post-transaction ownership figures for both categories.

Key Highlights

  • Kathryn Guarini sold 400 Regeneron shares at $850 per share.
  • Her reported share ownership after the sale was 603 shares.
  • Guarini owned 1,158 derivative securities after the option exercise.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) director Kathryn Guarini exercised options for 400 shares at $719.37 per share on Sept. 2, 2026. The transaction left Guarini with 1,003 shares.

Option Exercise

and $850 Share Sale Guarini also exercised options covering 400 derivative securities on Sept. 2, 2026. Her derivative-securities holdings stood at 1,158 after that transaction. A separate transaction involved the sale of 400 shares at $850 per share. Guarini’s reported share ownership following the sale was 603 shares. The option exercises carried transaction code M, while the share sale carried transaction code S.

Separate Ownership Positions Reported The

reported holdings distinguish between shares and derivative securities. Guarini held 603 shares after the sale and 1,158 derivative securities after the exercise. The source records the exercise price as $719.37 per share and the sale price as $850 per share. Both transactions took place on Sept. 2, 2026.